Amphastar Pharmaceuticals Current Ratio 2012-2024 | AMPH

Amphastar Pharmaceuticals current ratio from 2012 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Amphastar Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-09-30 $0.55B $0.16B 3.43
2024-06-30 $0.48B $0.14B 3.52
2024-03-31 $0.56B $0.26B 2.18
2023-12-31 $0.49B $0.23B 2.17
2023-09-30 $0.54B $0.26B 2.11
2023-06-30 $0.39B $0.25B 1.53
2023-03-31 $0.41B $0.11B 3.86
2022-12-31 $0.38B $0.10B 3.99
2022-09-30 $0.38B $0.10B 3.76
2022-06-30 $0.38B $0.10B 3.64
2022-03-31 $0.36B $0.11B 3.19
2021-12-31 $0.32B $0.10B 3.06
2021-09-30 $0.30B $0.10B 3.10
2021-06-30 $0.31B $0.13B 2.50
2021-03-31 $0.30B $0.13B 2.36
2020-12-31 $0.28B $0.11B 2.49
2020-09-30 $0.28B $0.10B 2.86
2020-06-30 $0.27B $0.09B 2.86
2020-03-31 $0.25B $0.08B 2.96
2019-12-31 $0.26B $0.09B 2.84
2019-09-30 $0.27B $0.09B 3.11
2019-06-30 $0.28B $0.10B 2.81
2019-03-31 $0.23B $0.11B 2.06
2018-12-31 $0.22B $0.11B 2.06
2018-09-30 $0.20B $0.10B 2.02
2018-06-30 $0.17B $0.09B 1.94
2018-03-31 $0.17B $0.07B 2.40
2017-12-31 $0.19B $0.07B 2.80
2017-09-30 $0.18B $0.06B 3.08
2017-06-30 $0.19B $0.06B 3.04
2017-03-31 $0.19B $0.07B 2.63
2016-12-31 $0.18B $0.06B 3.04
2016-09-30 $0.19B $0.06B 3.13
2016-06-30 $0.18B $0.07B 2.76
2016-03-31 $0.17B $0.07B 2.67
2015-12-31 $0.18B $0.06B 2.93
2015-09-30 $0.20B $0.07B 2.82
2015-06-30 $0.20B $0.07B 2.94
2015-03-31 $0.20B $0.07B 2.81
2014-12-31 $0.20B $0.06B 3.16
2014-09-30 $0.22B $0.06B 3.41
2014-06-30 $0.21B $0.06B 3.81
2014-03-31 $0.18B $0.07B 2.44
2013-12-31 $0.17B $0.07B 2.65
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.17B $0.06B 2.76
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2012-03-31 $0.00B 0.00
2011-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.097B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00